<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8106540</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6583</journal-id>
<journal-id journal-id-type="nlm-ta">Prenat Diagn</journal-id>
<journal-id journal-id-type="iso-abbrev">Prenat. Diagn.</journal-id>
<journal-title-group>
<journal-title>Prenatal diagnosis</journal-title>
</journal-title-group>
<issn pub-type="ppub">0197-3851</issn>
<issn pub-type="epub">1097-0223</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29297200</article-id>
<article-id pub-id-type="pmc">5828907</article-id>
<article-id pub-id-type="doi">10.1002/pd.5202</article-id>
<article-id pub-id-type="manuscript">NIHMS932828</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Utility of chromosomal microarray in anomalous fetuses</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Parchem</surname>
<given-names>Jacqueline G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sparks</surname>
<given-names>Teresa N.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gosnell</surname>
<given-names>Kristen</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Norton</surname>
<given-names>Mary E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology &amp; Reproductive Sciences, University of California, San Francisco, CA 94158</aff>
<aff id="A2">
<label>2</label>Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030</aff>
<aff id="A3">
<label>3</label>Division of Medical Genetics, Department of Pediatrics, University of California, San Francisco, CA 94158</aff>
<aff id="A4">
<label>4</label>Fetal Treatment Center, Benioff Children’s Hospital, University of California, San Francisco, CA 94158</aff>
<author-notes>
<corresp id="FN1"><bold>Corresponding Author:</bold> Jacqueline Parchem, MD, 6431 Fannin St, MSB 3.286, Houston, TX 77030, Phone: (415) 250-6257, <email>jparchem@mdanderson.org</email>, <email>jackieparchem@gmail.com</email></corresp>
<fn fn-type="current-aff" id="FN2">
<label>*</label>
<p>Current affiliations: Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, McGovern Medical School at The University of Texas Health Science Center at Houston, TX 77030; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030</p>
</fn>
<fn fn-type="COI-statement" id="FN3">
<p><bold>Disclosures</bold>: The other authors did not report any conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>10</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2019</year>
</pub-date>
<volume>38</volume>
<issue>2</issue>
<fpage>140</fpage>
<lpage>147</lpage>
<!--elocation-id from pubmed: 10.1002/pd.5202-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">To determine the association of copy number variants (CNV) with perinatal outcomes among fetuses with sonographic abnormalities.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">This was a retrospective cohort study of anomalous fetuses evaluated at a single fetal center, who underwent chromosomal microarray (CMA) testing. Pathogenic CNV or variants of uncertain significance (VUS) were classified as abnormal. The primary outcome of perinatal death was compared among fetuses with normal versus abnormal CMA. Secondary outcomes included preterm birth, small for gestational age birth weight, and death prior to discharge. The odds ratio (OR) of perinatal death was determined, adjusting for potential confounders.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Of 280 fetuses, 60 (21.4%) had abnormal CMA results – 21 (35.0%) were classified as pathogenic, 39 (65.0%) were VUS. Among 212 (75.7%) continuing pregnancies, abnormal CMA was not associated with increased odds of perinatal death (adjusted OR 0.81, 95% CI 0.34-1.93), after adjustment for the presence of hydrops and specific anomalies. The overall frequency of perinatal death was 21.2%. No differences in secondary outcomes were observed.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">Abnormal CMA was not associated with increased odds of perinatal death in this cohort. Fetal CNV are common among fetal center patients; such fetuses are at high risk of perinatal death irrespective of CMA results.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>